Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.
The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.
MorphoSys shares are currently gaining nearly 37%.

Source: xStation
USA Rare Earth Acquires Key Brazilian Rare Earth Metal Mines ⛏️
US OPEN: Return of geopolitical concerns hits markets 💥
New Player in Google’s Ecosystem? Marvell Triggers Market Reaction
Will Wall Street reach new record high?🗽Highlights from S&P 500 earnings season